The Asian Scientist 100
Chin Wei Lai
Institution
Universiti Malaya
Country
Malaysia
Field
Sustainability
Lai was one of the winners of Ten Outstanding Young Malaysians Award by the Junior Chamber International Malaysia for his work on using durable photocatalysis technology with nanomaterials to combat global warming and reduce environmental impacts.
(Photo: Shanghai Jiao Tong University)
AWARDS
- Ten Outstanding Young Malaysians Award
Related articles
Asia’s Scientific Trailblazers: Patrick Casey
It's been ten years since the launch of the Duke-NUS Graduate Medical School in Singapore. Professor Patrick Casey shares his thoughts on what the school has achieved and what lies ahead.
Cash: Friend Or Foe?
Research into cash-rich companies by SMU Assistant Professor Yuanto Kusnadi is revealing insights into corporate governance and shareholder value.
Sitting For Too Long May Kill You, Australian Study Says
A study has found that adults who sat 11 or more hours per day had a 40 percent increased risk of dying in the next three years versus those who sat for fewer than four hours a day.
Stay Cool And Eat Bamboo
Pandas can survive on a diet of bamboo thanks to their exceptionally low metabolic rate, scientists say.
Indulgent Grandparents Fuel Obesity In Chinese Kids
Overfeeding and protection from household chores are some ways grandparents are contributing to obesity in their grandkids.
Making Lithium Batteries Safer, Tougher & More Powerful
A pumpkin-shaped nanoparticle could help make lithium ion batteries less likely to explode while improving their performance at the same time.
The Secrets of Traditional Asian Beauty
We take a look at ancient natural beauty remedies that Asian women have been using for centuries.
Building A Better Battery: Storage Solutions For Asia’s Energy Goals
Asia has set ambitious renewable energy targets for itself but is still missing one crucial piece of the puzzle—ways to store power from intermittent renewable sources. Could homegrown technologies fill the gap?
CBMG Acquires CD40LGVAX Technologies
Building on positive Phase I results, the CD40LGVAX vaccine will undergo further trials in the second half of 2015.